WHC is still in active development. Read this to understand our approach.
depiction of HGRHWEAUHXYNNP-UHFFFAOYSA-N.svg
tripsit

5-meo-dalt

Verificar en tripsit

psychonaut

5-MeO-DALT

Verificar en psychonaut

isomerdesign

5-MeO-DALT

Verificar en isomerdesign

druglab

5-MeO-DALT

Verificar en druglab

wiki

5-MeO-DALT

Verificar en wiki

Data

InChI: InChI=1S/C17H22N2O/c1-4-9-19(10-5-2)11-8-14-13-18-17-7-6-15(20-3)12-16(14)17/h4-7,12-13,18H,1-2,8-11H2,3H3

Sinónimos: BCP06624,5-MeO-DALT (5-Methoxy-N,N-diallyltryptamine) 1.0 mg/ml in Acetonitrile,N,N-Diallyl-5-methoxy-1H-indole-3-ethanamine,5-Methoxy-N,N-diallyl-1H-indole-3-ethanamine,3-[2-(Diallylamino)ethyl]-5-methoxyindole,J-523223,5-methoxy DALT,CHEMBL2391541,V25VK0QTAA,N-Allyl-N-(2-(5-methoxy-1H-indol-3-yl)ethyl)prop-2-en-1-amine,Indole, 3-[2-(diallylamino)ethyl]-5-methoxy,5-Methoxy-DALT,A844374,5-MEO DALT,5-methoxy-N,N-diallyltryptamine,5-MeO-DALT solution, 1.0 mg/mL in acetonitrile, certified reference material,AKOS005145816,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-prop-2-enyl-prop-2-en-1-amine,1H-Indole-3-ethanamine, 5-methoxy-N,N-di-2-propen-1-yl-,BDBM50435344,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-prop-2-enylprop-2-en-1-amine,MFCD11655942,DTXSID30239169,N,N-DI ALLYL-5-METHOXY TRYPTAMINE,Q9134216,5-MeO-DALT (5-Methoxy-N,N-diallyltryptamine),N,N-Diallyl-5-methoxytryptamine,5-MeO DALT,5meodalt,N-Allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-prop-2-enyl-2-propen-1-amine,928822-98-4,AM20041417,N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine,ZINC40448582,142D640,Tryptamine, N,N-diallyl-5-methoxy,J-800202,CHEBI:190972,[2-(5-methoxy-1H-indol-3-yl)ethyl]bis(prop-2-en-1-yl)amine,J-640466,AC-8818,5-methoxy-n,n-di-2-propen-1-yl-1h-indole-3-ethanamine,5-METHOXY-DALT,5-Methoxy-N,N-diallyltryptamine,AS-30565,SCHEMBL15162217,5-MeO-DALT,UNII-V25VK0QTAA

Market name: 5-meo-dalt

Estimated data

Solubilidad: -2.833 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 87.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.